WW International Q3 revenue slightly beats estimates on clinical subscription growth

By Reuters News


Overview

  • Weight management program's Q3 revenue fell 11% yr/yr, slightly beating analyst expectations

  • Company posted positive net income after a loss in the prior-year quarter

  • Adjusted EBITDA rose 21% yr/yr, driven by expense discipline and lower marketing spend


Outlook

  • WW International narrows 2026 revenue guidance to $625 mln-$630 mln from $620 mln-$635 mln

  • Company raises lower end of 2026 adj EBITDA outlook to $110 mln-$115 mln from $105 mln-$115 mln

  • Company says it will focus on improving member experience and product offerings


Result Drivers

  • CLINICAL SUBSCRIPTION GROWTH - Co said 48% yr/yr growth in clinical subscription revenue contributed to results

  • CORE+ SUBSCRIBER INCREASE - 16% yr/yr growth in higher-value Core+ subscribers supported results

  • HIGHER ARPU - 14% yr/yr increase in monthly subscription revenue per average subscriber, driven by clinical and Core+ mix


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Beat*

$153 mln

$152.35 mln (3 Analysts)

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the personal services peer group is "buy"

  • Wall Street's median 12-month price target for WW International Inc is $27.50, about 126.7% above its November 4 closing price of $12.13


Reuters Recommended Reads

  • Nov 5 - Tapestry Q1 revenue and adjusted EPS beat estimates, outlook raised

  • Nov 5 - Warby Parker Q3 revenue rises on higher active customer count

  • Nov 5 - Elf sees Q2 sales boost with marketing, Europe expansion


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk